X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
index medicus (40) 40
female (32) 32
hematology (32) 32
life sciences (32) 32
male (32) 32
middle aged (32) 32
aged (27) 27
adult (26) 26
cancer (22) 22
oncology (20) 20
lymphoma (15) 15
retrospective studies (13) 13
aged, 80 and over (12) 12
treatment outcome (12) 12
adolescent (11) 11
rituximab (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
chemotherapy (10) 10
lymphomas (10) 10
transplantation (10) 10
trial (10) 10
neoplasm staging (9) 9
recurrence (9) 9
stem cell transplantation (9) 9
[ sdv.can ] life sciences [q-bio]/cancer (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
disease-free survival (8) 8
prognosis (8) 8
response criteria (8) 8
survival (8) 8
[sdv.can]life sciences [q-bio]/cancer (7) 7
abridged index medicus (7) 7
bone-marrow-transplantation (7) 7
follow-up studies (7) 7
hemic and lymphatic diseases (7) 7
human health and pathology (7) 7
prospective studies (7) 7
stem cells (7) 7
survival rate (7) 7
allografts (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
care and treatment (6) 6
disease (6) 6
hematology, oncology and palliative medicine (6) 6
immune system diseases (6) 6
leukemia (6) 6
positron-emission-tomography (6) 6
survival analysis (6) 6
therapy (6) 6
young adult (6) 6
[sdv]life sciences [q-bio] (5) 5
allogeneic stem cell transplantation (5) 5
analysis (5) 5
autografts (5) 5
france (5) 5
guidelines (5) 5
high-dose therapy (5) 5
hodgkin's disease (5) 5
lymphoma, mantle-cell - therapy (5) 5
mantle cell lymphoma (5) 5
patients (5) 5
risk factors (5) 5
transplantation, autologous (5) 5
[ sdv ] life sciences [q-bio] (4) 4
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (4) 4
acute myeloid-leukemia (4) 4
allogreffe (4) 4
bendamustine (4) 4
cyclophosphamide - administration & dosage (4) 4
cytarabine - administration & dosage (4) 4
drug resistance, neoplasm (4) 4
follow-up (4) 4
hematopoietic stem cell transplantation (4) 4
hematopoietic stem cell transplantation - standards (4) 4
hodgkin disease - therapy (4) 4
lymphoma, mantle-cell - drug therapy (4) 4
lymphoma, mantle-cell - mortality (4) 4
lymphome (4) 4
pet imaging (4) 4
randomized-trial (4) 4
recommandations (4) 4
remission induction (4) 4
societies, medical (4) 4
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (3) 3
age factors (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - adverse effects (3) 3
child (3) 3
combination (3) 3
combined modality therapy (3) 3
doxorubicin - administration & dosage (3) 3
doxorubicin - therapeutic use (3) 3
drug administration schedule (3) 3
efficacy (3) 3
elderly-patients (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 03/2016, Volume 101, Issue 4, pp. 466 - 473
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1250 - 1260
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 08/2017, Volume 44, Issue 8, pp. 1254 - 1257
Journal Article
Annals of Hematology, ISSN 0939-5555, 2/2014, Volume 93, Issue 2, pp. 233 - 242
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2018, Volume 36, Issue 20, pp. 2125 - 2126
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 08/2018, Volume 32, Issue 8, pp. 1768 - 1777
Journal Article
Haematologica, ISSN 0390-6078, 07/2012, Volume 97, Issue 7, pp. 1085 - 1091
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0172147 - e0172147
The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the... 
MORTALITY | SURVIVAL | RESONANCE | MORBIDITY | CHELATION-THERAPY | DEPENDENT PATIENTS | MULTIDISCIPLINARY SCIENCES | DISEASE | ACCUMULATION | BETA-THALASSEMIA | CHILDREN | Heart - physiopathology | Thalassemia - blood | Myelodysplastic Syndromes - physiopathology | Anemia, Sickle Cell - physiopathology | Humans | Middle Aged | Male | Myelodysplastic Syndromes - blood | Iron Overload - physiopathology | Iron Overload - blood | Blood Transfusion | Iron Chelating Agents | Myocardium - metabolism | Adolescent | Adult | Female | Anemia, Sickle Cell - blood | Thalassemia - physiopathology | Child | Iron - blood | Sickle cell anemia | Cardiac patients | Analysis | Thalassemia | Iron | Research | Health aspects | Myelodysplastic syndromes | Blood transfusions | Heart | Erythropoiesis | Pediatrics | Transferrin | Nuclear magnetic resonance--NMR | Transfusion | Laboratories | Liver | Ferritin | Disorders | Macrophages | Blood | Myelodysplastic syndrome | Red blood cells | Chelation | Hemoglobin | Sickle cell disease | Heart diseases | Age | Life expectancy | Hematology | Anemia | Research & development--R&D | Magnetic resonance | Inflammation | Patients | Coronary artery disease | Chromatography | Hospitals | Life span | Scientific imaging | Hepcidin | Mass spectrometry | Index Medicus | Research & development | Nuclear magnetic resonance | R&D | NMR
Journal Article